Improved gene transfer into human lymphocytes using retroviruses with the gibbon ape leukemia virus envelope

Human Gene Therapy

Volumn 7, Issue 12, 1996, Pages 1415-1422

  Lam, John S ^a   Reeves, Mark E ^a   Cowherd, Robert ^a   Rosenberg, Steven A ^a   Hwu, Patrick ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; MESSENGER RNA;

ARTICLE; CONTROLLED STUDY; GENE THERAPY; GENE TRANSFER; GIBBON LEUKEMIA VIRUS; HUMAN; HUMAN CELL; NONHUMAN; RETROVIRUS; SEQUENCE HOMOLOGY; T LYMPHOCYTE; VIRUS ENVELOPE;

EID: 0029788609     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.12-1415     Document Type: Article

References (41)

1. AURON, P., SULLIVAN, D., FENTON, M., CLARK, B., COLD, E., GALSON, D., PETERS, L., and TELLER, D. (1988). The nucleic acid blot analyzer. II. ANALYZE, an image analysis software package for molecular biology. BioTechniques 6, 347-353.
2. BAUER, T.R., JR., MILLER, A.D., and HICKSTEIN, D.D. (1995). Improved transfer of the leukocyte integrin CD18 subunit into hematopoietic cell lines by using retroviral vectors having a gibbon ape leukemia virus envelope. Blood 86, 2379-2387.
3. BLAESE, R.M., CULVER, K.W., MILLER, A.D., CARTER, C., FLEISHER, T., CLERICI, M., SHEARER, G. CHANG, L., CHIANG, Y., TOLSTOSHEV, P., GREENBLAST, J., ROSENBERG, S.A., KLEIN, H., BERGER, M., MULLEN, C., RAMSEY, J., MUUL, L., MORGAN, R.A., and ANDERSON, W.F. (1995). T lymphocyte gene therapy for ADA deficiency (SCID): Results of the initial trial with 4 years of observation. Science 270, 475-480.
4. BUNNELL, B.A., MUUL, L.M., DONAHUE, R.E., BLAESE, R.M., and MORGAN, R.A. (1995). High-efficiency retroviral-mediated gene transfer into humans and nonhuman primate peripheral blood lymphocytes. Proc. Natl. Acad. Sci. USA 92, 7739-7743.
5. CHIRGWIN, J., PRZYBYIA, A., MACDONALD, R., and RUTTER, W. (1979). Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18, 5294-5299.
6. CULVER, K., CORNETTA, K., MORGAN, R., MORECKI, S., AEBERSOLD, P., KASID, A., LOTZE, M., ROSENBERG, S.A., ANDERSON, W.F., and BLAESE, R.M. (1991). Lymphocytes as cellular vehicles for gene therapy in mouse and man. Proc. Natl. Acad. Sci. USA 88, 3155-3159.
7. CULVER, K., MORGAN, R.A., OSBORNE, W.R.A., LEE, R.T., LENSCHOW, D., ABLE, C., CORNETTA, K., ANDERSON, W.F., and BLAESE, R.M. (1990). In vivo expression and survival of gene-modified T lymphocytes in rhesus monkeys. Hum. Gene Ther. 1, 399-410.
8. DALGLEISH, A.G., BEVERLY, P.C.L., CLAPHAM, P.R., CRAWFORD, D.H., GREAVES, M.F., and WEISS, R.A. (1984). The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312, 763-767.
9. GLISIN, V., CRKVENJAKOV, R., and BYUS, C. (1974). Ribonucleic acid isolated by cesium chloride centrifugation. Biochemistry 13, 2633-2637.
10. HWU, P., SHAFER, G.E., TREISMAN, J., SCHINDLER, D.G., GROSS, G., COWHERD, R., ROSENBERG, S.A., and ESHHAR, Z. (1993a). Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor gamma chain. J. Exp. Med. 178, 361-366.
11. HWU, P., YANNELLI, J., KRIEGLER, M., ANDERSON, W.F., FEREZ, C., CHIANG, Y., SCHWARZ, S., COWHERD, R., DELGADO, C., MULE, J., and ROSENBERG, S.A. (1993b). Functional and molecular characterization of tumor-infiltrating lymphocytes transduced with tumor necrosis factor-α cDNA for the gene therapy of cancer in humans. J. Immunol. 150, 4104-4115.
12. HWU, P., YANG, J.C., COWHERD, R., TREISMAN, J., SHAFER, G.E., ESHHAR, Z., and ROSENBERG, S.A. (1995). In vivo antitumor activity of T cells redirected with chimeric antibody/T-cell receptor genes. Cancer Res. 55, 3369-3373.
13. KARASUYAMA, H., TOHYAMA, N., and TADA, T. (1989). Autocrine growth and tumorigenicity of interleukin 2-dependent helper T cells transfected with IL-2 gene. J. Exp. Med. 169, 13-25.
14. KASID, A., MORECKI, S., AEBERSOLD, P., CORNETTA, K., CULVER, K., FREEMAN, S., DIRECTOR, E., LOTZE, M., BLAESE, R.M., ANDERSON, W.F., and ROSENBERG, S.A. (1990). Human gene transfer: Characterization of human tumor-infiltrating lymphocytes as vehicles for retroviral-mediated gene transfer in man. Proc. Natl. Acad. Sci. USA 87, 473-477.
15. KAVANAUGH, M.P., MILLER, D.G., ZHANG, W., LAW, W., KOZAK, S.L., KABAT, D., and MILLER, A.D. (1994). Cell surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc. Natl. Acad. Sci. USA 91, 7071-7075.
16. KITAMURA, T., and MIYAJIMA, A. (1992). Functional reconstitution of the human interleukin-3 receptor. Blood 80, 84-90.
17. KIM, J.W., CLOSS, EI., ALBRITTON, L.M., and CUNNINGHAM, J.M. (1991). Transport of cationic amino acids by the mouse ecotropic retrovirus receptor. Nature 352, 725-728.
18. KLATZMANN, D., CHAMPAGNE, E., CHAMARET, S., GRUEST, J., GUETARD, D., HERCEND, T., GLUCKMAN, J.C., and MONTAGNIER, L. (1984). T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 312, 767-768.
19. LEAVITT, M.C., YU, M., YAMADA, O., KRAUS, G., LOONEY, D., POESCHLA, E., and WONG-STAAL, F. (1994). Transfer of an anti-HIV ribozyme gene into primary human lymphocytes. Hum. Gene Ther. 5, 115-120.
20. MANIATIS, T., FRITSCH, E., and SAMBROOK, J. (1982). Molecular Cloning: A Laboratory Manual. (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY).
21. MILLER, A.D., GARCIA, J.V., VON, S.N., LYNCH, C.M., WILSON, C., and EIDEN, M.V. (1991). Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J. Virol. 65, 2220-2224.
22. MILLER, A.D., and ROSMAN, G.J. (1989). Improved retroviral vectors for gene transfer and expression. BioTechniques 7, 980-988.
23. MILLER, A.D., and BUTTIMORE, C. (1986). Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol. 6, 2895-2902.
24. MILLER, D.G., ADAM, M.A., and MILLER, A.D. (1990). Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell. Biol. 10, 4239-4242.
25. MILLER, D.G., EDWARDS, R.H., and MILLER, A.D. (1994). Cloning of the cellular receptor for amphotropic murine retroviruses reveals homology to that for gibbon ape leukemia virus. Proc. Natl. Acad. Sci. USA 91, 78-82.
26. MORGAN, R.A., BALER-BITTERLICH, G., RAGHEB, J.A., WONG-STAAL, F., GALLO, R.C., and ANDERSON, W.F. (1994). Further evaluation of soluble CD4 as an anti-HIV type 1 gene therapy: Demonstration of protection of primary human peripheral blood lymphocytes from infection by HIV type 1. AIDS Res. Hum. Retrovir. 10, 1507-1515.
27. MORGAN, R.A., COUTURE, L., ELROY-STEIN, O., RAGHEB, J., MOSS, B., and ANDERSON, W.F. (1992). Retroviral vectors containing putative internal ribosome entry sites: development of a polycistronic gene transfer system and applications to human gene therapy. Nucleic Acids Res. 20, 1293-1299.
28. O'HARA, B., JOHANN, S.V., KLINGER, H.P., BLAIR, D.G., RUBINSON, H., DUNN, K.J., SASS, P. VITEK, S.M., and ROBINS, T. (1990). Characterization of a human gene conferring sensitivity to infection by gibbon ape leukemia virus. Cell. Growth Differ. 1, 119-127.
29. ROSENBERG, S.A., AEBERSOLD, P., CORNETTA, K., KASID, A., MORGAN, R., MOEN, R., KARSON, E., LOTZE, M., YANG, J., TOPALIAN, S. MERINO, M., CULVER, K., MILLER, A.D., BLAESE, R.M., and ANDERSON, W.F. (1990). Gene transfer into humans-immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. N. Engl. J. Med. 323, 570-578.
30. ROSENBERG, S.A., ANDERSON, W.F., BLAESE, R.M., HWU, P., YANNELLI, J.R., YANG, J.C., TOPALIAN, S.L., SCHWARTZ-ENTRUBER, D.J., WEBER, J.S., ETTINGHAUSEN, S.E., PARKINSON, D.N., and WHITE, D.E. (1993). The development of gene therapy for the treatment of cancer. Ann. Surg. 218, 455-464.
31. SCHNEIDER-GADICKE, A., BEER-ROMERO, P., BROWN, L., NUSSBAUM, R., and PAGE, D. (1989). ZFX has a gene structure similar to ZFY, the putative human sex determinant, and escapes X inactivation. Cell 57, 1247-1258.
32. SHOWERS, M.O., MOREAU, J.F., LINNEKIN, D., DRUKER, B., and D'ANDREA, A.D. (1992). Activation of the erythropoietin receptor by the friend spleen focus-forming virus gp55 glycoprotein induces constitutive protein tyrosine phosphorylation. Blood 80, 3070-3078.
33. SULLIVAN, D., AURON, P., QUIGLEY, G., WATKINS, P., and STANCHFIELD, J. (1987). The nucleic acid blot analyzer. I. High speed imaging and quantitation of P-32 labeled blots. BioTechniques 5, 672.
34. TOPALIAN, S., MUUL, L., SOLOMON, D., and ROSENBERG, S.A. (1987). Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials. J. Immunol. Methods 102, 127-141.
35. TREISMAN, J., HWU, P., MINAMOTO, S., SHAFER, G.E., COWHERD, R., MORGAN, R.A., and ROSENBERG, S.A. (1995). Interleukin-2-transduced lymphocytes grow in an autocrine fashion and remain responsive to antigen. Blood 85, 139-145.
36. ULLRICH, A., SHINE, J., CHIRGWIN, J., PICTET, R., TISCHER, E., RUTTER, W., and GOODMAN, H. (1977). Rat insulin genes: construction of plasmids containing the coding sequences. Science 196, 1313-1319.
37. VAN ZEIJL, M., JOHANN, S.V., CLOSS, E., CUNNINGHAM, J., EDDY, R., SHOWS, T.B., and O'HARA, B. (1994). A human amphotropic retrovirus receptor is a second member of the gibbon ape leukemia virus receptor family. Proc. Natl. Acad. Sci. USA 91, 1168-1172.
38. WANG, H., KAVANAUGH, M.P., NORTH, R.A., and KABAT, D. (1991). Cell-surface receptor for ecotropic murine retroviruses is a basic amino-acid transporter. Nature 352, 729-731.
39. YAMADA, G., KITAMURA, Y., SONODA, H., HARADA, H., TAKI, S., MULLIGAN, R.C., OSAWA, H., DIAMANTSTEIN, T., YOKOYAMA, S., and TANIGUCHI, T. (1987). Retroviral expression of the human IL-2 gene in a murine T cell line results in cell growth autonomy and tumorigenicity. EMBO J. 6, 2705-2709.
40. YANNELLI, J. (1991). The preparation of effector cells for use in the adoptive cellular immunotherapy of human cancer. J. Immunol. Methods 139, 1-16.
41. ZHANG, H., DUAN, L.X., DORNADULA, G., and POMERANTZ, R.J. (1995). Increasing transduction efficiency of recombinant murine retrovirus vectors by initiation of endogenous reverse transcription: potential utility for genetic therapies. J. Virol. 69, 3929-3932.